NooCube combines B vitamins, botanical extracts and antioxidant compounds — including Bacopa Monnieri, Alpha GPC and Huperzine A — into a single daily capsule the company markets as caffeine-free, entering a nootropics category with a growing independent research base but no clinical trial of the finished, thirteen-ingredient product itself.
Boise, Idaho, September 6, 2026 — NooCube, a nootropic dietary supplement manufactured by Wolfson Brands (UK) Limited — the same manufacturer behind TestoPrime and PhenQ — combines thirteen ingredients into a stimulant-free daily capsule the company markets as supporting focus, memory and mental clarity. The company discloses all thirteen ingredients individually on the product label rather than grouping them into an undisclosed proprietary blend.
“Formulation transparency is fundamental to how we develop our products at Wolfson Brands,” said Neil Browers, Product Support at Wolfson Brands (UK) Limited. “By declaring every single ingredient and keeping the entire blend 100% caffeine-free, NooCube gives consumers the clear facts they need to make informed decisions about their daily cognitive wellness.”
What NooCube Is
NooCube is launched as a dietary supplement, not a prescription medication or a treatment for any diagnosed cognitive condition. It contains no caffeine or other stimulants, which the company positions as a differentiator from stimulant-based nootropic and energy products. It is marketed to a broad range of adults, including students, professionals and older adults interested in general cognitive wellness rather than a diagnosed neurological condition.
The 13-Ingredient Formula
According to information published by the manufacturer, NooCube combines: Vitamin B1 (thiamine), Vitamin B7 (biotin), Vitamin B12, Bacopa Monnieri, L-Tyrosine, Cat’s Claw extract, Oat Straw extract, L-Theanine, Alpha GPC, Huperzine A (from Huperzia serrata), Lutemax 2020 (a marigold-derived carotenoid blend), Resveratrol and Pterostilbene.
Alpha GPC is a choline compound the body absorbs efficiently, and choline is a documented precursor to acetylcholine, a neurotransmitter involved in memory formation and learning. Choline-based ingredients are among the more consistently studied compounds in the nootropic category for this reason, though most trials examine choline status broadly rather than NooCube’s specific dose in isolation.
Huperzine A, derived from the Huperzia serrata plant, is studied for its effect on acetylcholinesterase, the enzyme responsible for breaking down acetylcholine after it has been used at the synapse. Inhibiting that enzyme is the proposed mechanism by which Huperzine A may support sustained acetylcholine availability; the bulk of the supporting research examines the isolated compound, often in different populations and at different doses than what appears in NooCube.
Bacopa Monnieri is an Ayurvedic herb with one of the more substantial clinical research bases among nootropic botanicals, generally examining memory-related outcomes after eight to twelve weeks of consistent daily use rather than a single-dose or short-term effect. The company includes it as part of NooCube’s longer-term, cumulative-use positioning rather than as an immediate-effect ingredient.
L-Theanine and L-Tyrosine are amino acids studied for distinct roles: L-Theanine for promoting calm alertness, sometimes examined in combination with caffeine in other products (NooCube itself contains no caffeine), and L-Tyrosine for supporting mental performance under conditions of stress or fatigue, based on its role as a precursor to catecholamine neurotransmitters including dopamine and norepinephrine.
Cat’s Claw and Oat Straw are botanical extracts the company includes for general antioxidant and nervous-system support roles; the independent research base for both, specifically regarding cognitive outcomes, is smaller and less consistent than for ingredients like Bacopa Monnieri or Alpha GPC.
Lutemax 2020 is a branded carotenoid blend (lutein, zeaxanthin and meso-zeaxanthin) studied primarily in the context of eye health and blue-light filtering; its inclusion in a cognitive supplement reflects a secondary, less-established line of research into a proposed eye-brain connection relevant to visual processing speed, rather than a memory- or focus-specific mechanism.
Resveratrol and Pterostilbene are polyphenol compounds studied largely for antioxidant and cellular-aging-related activity; cognitive-specific human trials for either compound at the doses typically used in supplements are limited.
How the Ingredients Are Positioned to Work Together
The company groups NooCube’s thirteen ingredients around three broad categories rather than a single mechanism: neurotransmitter support (Alpha GPC, Huperzine A, L-Tyrosine), stress and alertness balance (L-Theanine, Bacopa Monnieri), and antioxidant or cellular-health support (Resveratrol, Pterostilbene, Lutemax 2020, Cat’s Claw, Oat Straw), with the B vitamins positioned as foundational cofactors for normal nervous-system function. This is a description of formulation intent, not a claim of demonstrated combined effect, and the company has not published or cited a clinical trial testing the thirteen-ingredient combination as a single product.
Market Context
The figures below are sourced from third-party market research and are not claims made by Wolfson Brands regarding NooCube’s own commercial performance. According to Grand View Research, the global brain health supplements market was valued at approximately $8.63 billion in 2022 and is projected to grow at a compound annual growth rate of 13.3% from 2023 through 2030. The firm attributes growth in this category partly to rising interest in cognitive performance among students and working professionals, and to demand for stimulant-free alternatives to caffeine-based focus products. This release could not independently verify a more recent, updated figure specific to 2024 at the time of publication; readers should treat any more current market-size figure as unconfirmed pending direct verification against Grand View Research’s current published report.
Ingredient-level research of this kind describes studies conducted on individual compounds, often at different doses and in different populations than NooCube’s finished formula. It does not establish that the complete thirteen-ingredient product improves memory, focus or cognitive performance as a combined formula. No clinical trial of the finished NooCube product has been published or cited by the manufacturer.
Who the Product Is Marketed To
NooCube is marketed toward adults seeking general cognitive support — described by the manufacturer as useful for students, professionals and older adults — rather than individuals with a diagnosed cognitive or neurological condition. Anyone experiencing persistent memory loss, confusion or other concerning cognitive symptoms should consult a physician rather than self-treat with a supplement.
Safety Considerations
NooCube is formulated from vitamins, amino acids and botanical extracts generally regarded as suitable for adult use, but individual ingredients are not free of interaction risk. Huperzine A affects acetylcholine activity and is generally advised against for individuals with certain heart conditions, seizure disorders, or those taking related medications without medical supervision. Bacopa Monnieri has been associated in some individuals with mild digestive upset when taken without food. Anyone with an existing medical condition, anyone taking prescription medication, and anyone who is pregnant or nursing should consult a physician before use. NooCube is not intended for use by anyone under 18.
Frequently Asked Questions
Does NooCube contain stimulants? No. The company states the formula is free of caffeine and other stimulants.
Has NooCube been clinically proven to improve memory or focus? No clinical trial of the finished, thirteen-ingredient NooCube formula has been published. Several individual ingredients, including Bacopa Monnieri and Alpha GPC, have supportive research in specific contexts; that research does not establish the effect of the combined product.
Who manufactures NooCube? Wolfson Brands (UK) Limited, a Glasgow-based supplement company that also produces TestoPrime and PhenQ.
Are there safety concerns? Huperzine A can interact with certain heart medications and is generally not recommended for people with seizure disorders. Anyone with a medical condition or taking prescription medication should consult a physician before starting NooCube.
How is NooCube taken? As a daily capsule regimen; specific serving instructions should be confirmed on current product labeling.
How long before effects are noticeable? The company and third-party sources commonly describe a distinction between ingredients like L-Theanine and L-Tyrosine, which may have a same-day effect on alertness, and ingredients like Bacopa Monnieri, where research generally examines outcomes after eight or more weeks of consistent use. No clinical timeline has been established for the finished thirteen-ingredient product.
Can NooCube be taken with other supplements? The company states NooCube can generally be combined with other wellness supplements such as multivitamins, though anyone taking prescription medication or other nootropic products should check for overlapping ingredients and consult a physician.
Availability
NooCube is distributed exclusively through Wolfson Brands’ official website. Pricing, package configurations and refund terms are set by the manufacturer and subject to change.
About NooCube
NooCube is a nootropic dietary supplement manufactured by Wolfson Brands (UK) Limited, a Glasgow-based supplement company whose portfolio also includes TestoPrime and PhenQ. NooCube combines thirteen vitamin, amino-acid and botanical ingredients — all individually disclosed rather than grouped into a proprietary blend — in a stimulant-free daily capsule, sold direct-to-consumer through the official NooCube website. The company states NooCube is manufactured in a GMP-certified facility and describes the product as non-GMO and free of common allergens including gluten and soy; this release has not independently verified current certification status.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Ingredient-level research cited in this release pertains to individual compounds studied independently and does not establish the safety or efficacy of the finished product. This product is not a substitute for medical advice, diagnosis or treatment. Consult a licensed healthcare professional before use, particularly if managing an existing medical condition, taking prescription medication, or if pregnant or nursing. Individual results vary.
This release does not include any third-party images. NooCube and associated marks are trademarks of Wolfson Brands (UK) Limited; all other trademarks referenced are the property of their respective owners.
Media Contact
Neil Browers, Product Support, Wolfson Brands (UK) Limited (manufacturer of NooCube)
Email: support@noocube.com
Phone: +1 (970) 671-7706 12
Address: Payne Street, Glasgow, G4 0LF, United Kingdom
For more press release distribution and guest post services, visit TS Newswire.
